253 related articles for article (PubMed ID: 20974991)
21. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia.
Okamura A; Harada K; Nio M; Nakanuma Y
J Clin Pathol; 2013 Feb; 66(2):99-108. PubMed ID: 23162109
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
23. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
24. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
25. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M
J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
[TBL] [Abstract][Full Text] [Related]
26. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
27. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
[TBL] [Abstract][Full Text] [Related]
28. CCL26 in primary biliary cholangitis - Is it a novel disease mediator?
Sun X; Cao Y; Wang L; Chen H; Zhang F
Int J Rheum Dis; 2023 Apr; 26(4):648-656. PubMed ID: 36807869
[TBL] [Abstract][Full Text] [Related]
29. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation.
Ottaviani C; Nasorri F; Bedini C; de Pità O; Girolomoni G; Cavani A
Eur J Immunol; 2006 Jan; 36(1):118-28. PubMed ID: 16323244
[TBL] [Abstract][Full Text] [Related]
30. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation.
Gaspar K; Kukova G; Bunemann E; Buhren BA; Sonkoly E; Szollosi AG; Muller A; Savinko T; Lauerma AI; Alenius H; Kemeny L; Dieu-Nosjean MC; Stander S; Fischer JW; Ruzicka T; Zlotnik A; Szegedi A; Homey B
J Dermatol Sci; 2013 Jul; 71(1):12-21. PubMed ID: 23702389
[TBL] [Abstract][Full Text] [Related]
31. Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells.
Abonyo BO; Lebby KD; Tonry JH; Ahmad M; Heiman AS
Cytokine; 2006 Dec; 36(5-6):237-44. PubMed ID: 17350279
[TBL] [Abstract][Full Text] [Related]
32. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
33. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system.
Morita Y; Matsuda M; Hanamoto H; Shimada T; Tatsumi Y; Maeda Y; Kanamaru A
Clin Immunol; 2004 Oct; 113(1):109-16. PubMed ID: 15380536
[TBL] [Abstract][Full Text] [Related]
34. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells.
Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD
Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721
[TBL] [Abstract][Full Text] [Related]
35. Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.
Fevang B; Yndestad A; Damås JK; Bjerkeli V; Ueland T; Holm AM; Beiske K; Aukrust P; Frøland SS
Clin Immunol; 2009 Feb; 130(2):151-61. PubMed ID: 18938112
[TBL] [Abstract][Full Text] [Related]
36. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
[TBL] [Abstract][Full Text] [Related]
37. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.
Nishimura M; Umehara H; Nakayama T; Yoneda O; Hieshima K; Kakizaki M; Dohmae N; Yoshie O; Imai T
J Immunol; 2002 Jun; 168(12):6173-80. PubMed ID: 12055230
[TBL] [Abstract][Full Text] [Related]
38. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes.
Nomiyama H; Hieshima K; Nakayama T; Sakaguchi T; Fujisawa R; Tanase S; Nishiura H; Matsuno K; Takamori H; Tabira Y; Yamamoto T; Miura R; Yoshie O
Int Immunol; 2001 Aug; 13(8):1021-9. PubMed ID: 11470772
[TBL] [Abstract][Full Text] [Related]
39. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
40. Defective antitumor responses in CX3CR1-deficient mice.
Yu YR; Fong AM; Combadiere C; Gao JL; Murphy PM; Patel DD
Int J Cancer; 2007 Jul; 121(2):316-22. PubMed ID: 17372897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]